Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction

Clinical Science

Volumn 108, Issue 2, 2005, Pages 121-128

  Nyström, Thomas ^a   Nygren, Arne ^a   Sjöholm, Åke ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Adiponectin; C reactive protein (CRP); Coronary artery disease; Endothelial dysfunction; Type II diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLYCERYL TRINITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ADIPONECTIN; AGED; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; RISK FACTORS; VASODILATION;

EID: 12944284668     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040243     Document Type: Article

References (38)

1. Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K. and Laakso, M. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339, 229-234
2. Zimmet, P. Z. and Alberti, K. G. (1997) The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet 350 (Suppl. 1), SI1-SI4
3. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126
4. Biegelsen, E. S. and Loscalzo, J. (1999) Endothelial function and atherosclerosis. Coron. Artery Dis. 10, 241-256
5. Corretti, M. C., Anderson, T. J., Benjamin, E. J. et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39, 257-265
6. Furchgott, R. F. (1996) The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA, J. Am. Med. Assoc. 276, 1186-1188
7. Thorne, S., Mullen, M. J., Clarkson, P., Donald, A. E. and Deanfield, J. E. (1998) Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J. Am. Coll. Cardiol. 32, 110-116
8. Anderson, T. J., Uehata, A., Gerhard, M. D. et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26, 1235-1241
9. Halcox, J. P., Schenke, W. H., Zalos, G. et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658
10. Schachinger, V., Britten, M. B. and Zeiher, A. M. (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899-1906
11. Ridker, P. M., Stampfer, M. J. and Rifai, N. (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA, J. Am. Med. Assoc. 285, 2481-2485
12. Kinjo, K., Sato, H., Ohnishi, Y. et al. (2003) Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am. J. Cardiol. 91, 931-935
13. Chandran, M., Phillips, S. A., Ciaraldi, T. and Henry, R. R. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26, 2442-2450
14. Chen, H., Montagnani, M., Funahashi, T., Shimomura, I. and Quon, M. J. (2003) Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278, 45021-45026
15. No authors listed. (2000) Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21, 1502-1513
16. Celermajer, D. S., Sorensen, K. E., Gooch, V. M. et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 1111-1115
17. Wendelhag, I., Liang, Q., Gustavsson, T. and Wikstrand, J. (1997) A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 28, 2195-2200
18. Bland, J. M. and Altman, D. G. (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i, 307-310
19. Fichtlscherer, S., Rosenberger, G., Walter, D. H., Breuer, S., Dimmeler, S. and Zeiher, A. M. (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102, 1000-1006
20. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. and Munzel, T. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678
21. Pradhan, A. D. and Ridker, P. M. (2002) Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur. Heart J. 23, 831-834
22. Libby, P. and Ridker, P. M. (1999) Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100, 1148-1150
23. Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E. and Ridker, P. M. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, J. Am. Med. Assoc. 286, 327-334
24. Bhakdi, S., Torzewski, M., Klouche, M. and Hemmes, M. (1999) Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler., Thromb., Vasc. Biol. 19, 2348-2354
25. Verma, S., Wang, C. H., Li, S. H. et al. (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106, 913-919
26. Marfella, R., Quagliaro, L., Nappo, F., Ceriello, A. and Giugliano, D. (2001) Acute hyperglycemia induces an oxidative stress in healthy subjects. J. Clin. Invest. 108, 635-636
27. Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C. and Brownlee, M. (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108, 1341-1348
28. Federici, M., Menghini, R., Mauriello, A. et al. (2002) Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106, 466-472
29. Marfella, R., Siniscalchi, M., Esposito, K. et al. (2003) Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26, 3129-3135
30. Hotta, K., Funahashi, T., Arita, Y. et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler., Thromb., Vasc. Biol. 20, 1595-1599
31. Ouchi, N., Kihara, S., Funahashi, T. et al. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671-674
32. Pischon, T., Girman, C. J., Hotamisligil, G. S., Rifai, N., Hu, F. B. and Rimm, E. B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, J. Am. Med. Assoc. 291, 1730-1737
33. Krakoff, J., Funahashi, T., Stehouwer, C. D. et al. (2003) Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26, 1745-1751
34. Ritchie, S. A., Ewart, M.-A., Perry, C. G., Connell, J. M. C. and Salt, I. P. (2004) The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin. Sci. 107, 519-532
35. Schachinger, V. and Zeiher, A. M. (1995) Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis. Circulation 92, 2087-2094
36. Adams, M. R., Robinson, J., McCredie, R. et al. (1998) Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J. Am. Coll. Cardiol. 32, 123-127
37. Tesfamariam, B. and Cohen, R. A. (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 263, H321-H326
38. Mehta, J. L. (1995) Endothelium, coronary vasudilation, and organic nitrates. Am. Heart J. 129, 382-391